ctDNA as a prognostic biomarker in resectable CLM: Systematic review and meta-analysis.

Open Life Sci · 2023 · PMC10224622 · PMID 37250841

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

However, various discrepancies in the status of detection markers in plasma and tissues have been reported, and antitumor treatment and metastatic location may be significant variables affecting this discrepancy [ 56 ].

also in 4,529 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.